Health Care · Laboratory Analytical Instruments · Nasdaq · CIK 1001907 · FYE Jun 30 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $6.21Day −3.12%Mkt cap $121M1Y +15.0%Off 52W high −91.0%Vol (1Y) 502.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,292 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.5% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.01% |
| Top-10 13F concentration99.8% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.0M |
| Earnings (TTM)-$14.1M |
| ROE−48.7% |
| Net margin−1385.0% |
| Sales growth 3Y4.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+79.5% |
| 1Y+15.0% |
| 3Y−51.1% |
| 5Y−80.7% |
| 10Y−97.7% |
| Since incept. (ann.)−25.1% |
Total return through 2026-07-29 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)502.2% |
| Ann. volatility (3Y)292.3% |
| Sharpe (1Y)0.89 |
| Sharpe (3Y)0.44 |
| Max drawdown (1Y)−87.5% |
| Max drawdown (3Y)−87.5% |
| Beta (3Y vs SPY)9.98 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| J. Safra Sarasin Holding AG | 27,300 | $140,049 | 0.14% | new |
| BlackRock, Inc. | 20,188 | $105,583 | 0.10% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 19,347 | $101,200 | 0.10% | +3.0% |
| T3 Companies, LLC | 13,393 | $70,045 | 0.07% | new |
| SCS Capital Management LLC | 11,761 | $61,510 | 0.06% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,205 | $48,142 | 0.05% | new |
| VANGUARD FIDUCIARY TRUST CO | 4,339 | $22,693 | 0.02% | new |
| Caitong International Asset Management Co., Ltd | 4,037 | $21,114 | 0.02% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | — | — | $343,000 | −35.8% |
| 2025-12-31 | 2026-02-13 | — | — | $148,000 | −43.3% |
| 2025-09-30 | 2025-11-13 | — | — | $297,000 | +773.5% |
| 2025-06-30 | 2025-09-25 | — | — | $220,000 | +197.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
US 70% · Non Us 30%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
